Ultrasound developer EchoNous has received U.S. Food and Drug Administration (FDA) clearance for its Kosmos platform handheld ultrasound scanner.
Kosmos uses machine learning to imitate the human learning and decision-making process, according to EchoNous. It includes an 8-oz ultrasound-based tool with embedded and synchronized ECG and digital auscultation that is combined with deep learning for clinical assessment of the heart, lungs, and abdomen.
Also, the platform comes with a tablet called the Kosmos Bridge, on which artificial intelligence computation functions run. This eliminates the need for cloud connectivity during use and ensures no drops in service during scanning, according to the company.
In other news, EchoNous plans to file for FDA clearance of a trio of algorithms that will enable users to have their image quality graded, their technique guided, and the heart anatomy labeled by machine-learning algorithms.
